IL37 and Eczematoid dermatitis: Although there were no significant differences, the HRs were greater for IL-12/23 inhibitor exposures (HR, 1.07; 95% CI, 0.74-1.56) and IL-23 inhibitor exposures (HR, 1.25; 95% CI, 0.65-2.44) than for TNF inhibitor exposures; the opposite was observed for paradoxical eczema.